Therapy innovation for the treatment of pancreatic neuroendocrine tumors
Ferdinando Riccardi(Ospedale Antonio Cardarelli), Giacomo Cartenì(Ospedale Antonio Cardarelli), Carlo Molino(Fatebenefratelli Hospital), Lucia Festino(Ospedale Antonio Cardarelli), Francesca Ambrosio(Azienda Ospedaliero-Universitaria Careggi), Mimma Rizzo(University of Pavia), Generoso Uomo(Ospedale Antonio Cardarelli)
Cited by 8
Related Papers
Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
|Nature Genetics|1996|1.6k
Clinical and genetic characteristics of hereditary pancreatitis in Europe
|Clinical Gastroenterology and Hepatology|2004|615
Determinant-Based Classification of Acute Pancreatitis Severity
|Annals of Surgery|2012|516
Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
|Clinical Cancer Research|2019|240
First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial
|Journal of Clinical Oncology|2012|234